← FDA ENFORCEMENT
D-0871-2026Class II

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Product type
Drug
Status
Ongoing
Report date
2026-09-30
Distribution
Nationwide in the USA.
Firm state
NY
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Lack of Assurance of Sterility

Product description

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15

Code / lot info

Lot #: RL25G04, Exp. Date 07/2027; RL2H02, Exp. Date 08/2027.

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →